Exosens SAS

Geopolitical Instability Will Pressure Global Defense Margins

AnalystLowTarget

Not Invested

Consensus Narrative from 7 Analysts

Published

02 Aug 25

AnalystLowTarget's Fair Value

€33.50

9.4% overvalued

04 Sep

€36.65

81.2%

-6.7%

81.2%

-6.7%

Edit anytime before Aug 2 10:18 PM. Then post Updates to your followers.

Author's Valuation

€33.5

9.4% overvalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

€33.5

9.4% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

11.52%

Aerospace & Defense revenue growth rate

0.43%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.22%

Calculation

€101.50m

Earnings '28

20.33x

PE Ratio '28

€2.06b

Market Cap '28

€2.06b

Market Cap '28

50.73m

No. shares '28

€40.67

Share Price '28

€40.67 Share Price '28

Discounted to 2025 @ 7.20% p.a.

€33.02

Fair Value '25